目的观察开心散治疗乳腺癌失眠症患者的临床疗效及对血清5-羟色胺(5-hydroxytryptamine,5-HT)水平的影响。方法将63例乳腺癌失眠症患者随机分为对照组33例和治疗组30例。对照组患者采用艾司唑仑治疗,治疗组患者采用开心散联合艾司唑仑...目的观察开心散治疗乳腺癌失眠症患者的临床疗效及对血清5-羟色胺(5-hydroxytryptamine,5-HT)水平的影响。方法将63例乳腺癌失眠症患者随机分为对照组33例和治疗组30例。对照组患者采用艾司唑仑治疗,治疗组患者采用开心散联合艾司唑仑治疗。比较两组治疗前后匹兹堡睡眠质量指数量表(Pittsburgh sleep quality index,PSQI)、抑郁自评量表(self-rating depression scale,SDS)、焦虑自评量表(self-rating anxiety scale,SAS)、欧洲癌症研究和治疗协作组编制的癌症患者生活质量评分(European organization for research and treatment of cancer quality of life questionnaire-core 30,EORTC QLQ-C30)以及血清5-HT水平;在连续治疗4周后,比较两组临床疗效及不良反应发生率。结果治疗4周后,两组PSQI、SDS、SAS评分均较治疗前显著降低(P<0.05),且治疗组PSQI评分显著低于对照组(P<0.05);治疗组EORTC QLQ-C30躯体功能、情绪功能、认知功能以及社会功能评分均显著高于对照组(P<0.05);两组患者治疗后血清5-HT水平较治疗前显著升高(P<0.05),且治疗组血清5-HT水平高于对照组(P<0.05);治疗组疗效优于对照组(P<0.05);治疗组总不良反应发生率低于对照组,差异有统计学意义(P<0.05)。结论相较于单纯艾司唑仑治疗,开心散联合艾司唑仑能更好地改善乳腺癌患者睡眠,升高血清5-HT水平,提高乳腺癌患者生活质量,降低不良反应发生率。展开更多
A new compound K6FeNb15O42 u(?) prepared for the first time by solid state reaction in K2O-Fe2O3-Nb2O5 ternary system. The XRD data of the title compound was determined. K6FeNb15O42 crystallizes the hexagonal system w...A new compound K6FeNb15O42 u(?) prepared for the first time by solid state reaction in K2O-Fe2O3-Nb2O5 ternary system. The XRD data of the title compound was determined. K6FeNb15O42 crystallizes the hexagonal system with unit cell parameters a=9. 1320(4) A,c=12. 0670(9) A, and space group P63/mcm(193) , 2=1. The calculated and measured densities are 4. 489 g/ cm3 and 4. 485 g. cm3, respectively.展开更多
In the present paper, the concentration effect of near-infrared quantum cutting of Tm3＋ ion in （Y1-xTmx）3Al5Ol2 powder phosphor is studied by means of experiments and calculations. In addition, the absorption spect...In the present paper, the concentration effect of near-infrared quantum cutting of Tm3＋ ion in （Y1-xTmx）3Al5Ol2 powder phosphor is studied by means of experiments and calculations. In addition, the absorption spectra, visible-to-near- infrared excitation and emission spectra, and fluorescence lifetimes are measured. It is found that （Y1-xTmx）3Al5O12 powder phosphor has a strong four-photon near-infrared quantum cutting luminescence of 1788.0-nm 3F4 →3H6 fluores- cence of Tm3＋ ion, when excited by 357.0-nm light. It is also found that the up-limit of the four-photon near-infrared quantum cutting luminescence efficiency of （Yo.700Tmo.300）3Al5 O12 powder phosphor is approximately 302.19%. To the knowledge of the authors, this is the first time that a near-infrared quantum cutting efficiency up-limit exceeding 300% has been reported. The results of this manuscript are valuable in aiding the probing of the new generation Ge solar cell.展开更多
文摘目的观察开心散治疗乳腺癌失眠症患者的临床疗效及对血清5-羟色胺(5-hydroxytryptamine,5-HT)水平的影响。方法将63例乳腺癌失眠症患者随机分为对照组33例和治疗组30例。对照组患者采用艾司唑仑治疗,治疗组患者采用开心散联合艾司唑仑治疗。比较两组治疗前后匹兹堡睡眠质量指数量表(Pittsburgh sleep quality index,PSQI)、抑郁自评量表(self-rating depression scale,SDS)、焦虑自评量表(self-rating anxiety scale,SAS)、欧洲癌症研究和治疗协作组编制的癌症患者生活质量评分(European organization for research and treatment of cancer quality of life questionnaire-core 30,EORTC QLQ-C30)以及血清5-HT水平;在连续治疗4周后,比较两组临床疗效及不良反应发生率。结果治疗4周后,两组PSQI、SDS、SAS评分均较治疗前显著降低(P<0.05),且治疗组PSQI评分显著低于对照组(P<0.05);治疗组EORTC QLQ-C30躯体功能、情绪功能、认知功能以及社会功能评分均显著高于对照组(P<0.05);两组患者治疗后血清5-HT水平较治疗前显著升高(P<0.05),且治疗组血清5-HT水平高于对照组(P<0.05);治疗组疗效优于对照组(P<0.05);治疗组总不良反应发生率低于对照组,差异有统计学意义(P<0.05)。结论相较于单纯艾司唑仑治疗,开心散联合艾司唑仑能更好地改善乳腺癌患者睡眠,升高血清5-HT水平,提高乳腺癌患者生活质量,降低不良反应发生率。
文摘A new compound K6FeNb15O42 u(?) prepared for the first time by solid state reaction in K2O-Fe2O3-Nb2O5 ternary system. The XRD data of the title compound was determined. K6FeNb15O42 crystallizes the hexagonal system with unit cell parameters a=9. 1320(4) A,c=12. 0670(9) A, and space group P63/mcm(193) , 2=1. The calculated and measured densities are 4. 489 g/ cm3 and 4. 485 g. cm3, respectively.
基金Project supported by the National Natural Science Foundation of China(Grant No.10674019)the Significant Project of Fundamental Research Funds for the Central Universities of China(Grant No.212-105560GK)
文摘In the present paper, the concentration effect of near-infrared quantum cutting of Tm3＋ ion in （Y1-xTmx）3Al5Ol2 powder phosphor is studied by means of experiments and calculations. In addition, the absorption spectra, visible-to-near- infrared excitation and emission spectra, and fluorescence lifetimes are measured. It is found that （Y1-xTmx）3Al5O12 powder phosphor has a strong four-photon near-infrared quantum cutting luminescence of 1788.0-nm 3F4 →3H6 fluores- cence of Tm3＋ ion, when excited by 357.0-nm light. It is also found that the up-limit of the four-photon near-infrared quantum cutting luminescence efficiency of （Yo.700Tmo.300）3Al5 O12 powder phosphor is approximately 302.19%. To the knowledge of the authors, this is the first time that a near-infrared quantum cutting efficiency up-limit exceeding 300% has been reported. The results of this manuscript are valuable in aiding the probing of the new generation Ge solar cell.
